1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Composite grading algorithm for National Cancer Institute's PRO-CTCAE
    Meeting Abstract

    Dueck, A. C.; Becker, C. C.; Rogak, L. J.; Schrag, D.; Reeve, B.; Spears, P.; Smith, M. L.; Gounder, M. M.; Mahoney, M. R.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts
    Meeting Abstract

    Chen, J. L.; Mahoney, M. R.; George, S.; Antonescu, C. R.; Liebner, D. A.; Van Tine, B. A.; Milhem, M. M.; Tap, W. D.; Streicher, H.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining patient-elicited concepts unique to adolescents and young adults with cancer
    Meeting Abstract

    Avutu, V.; Lynch, K.; Barnett, M.; Vera, J.; Glade Bender, J. L.; Tap, W. D.; Atkinson, T. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Activating mutations in uveal melanoma convey sensitivity to g-alpha q inhibition
    Meeting Abstract

    Hitchman, T. D.; Ceraudo, E.; Moore, A. R.; Shoushtari, A. N.; Francis, J. H.; Guan, Y.; Chen, J.; Chang, M. T.; Taylor, B. S.; Sakmar, T. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical benefit with ripretinib as ≥4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study
    Meeting Abstract

    Zalcberg, J. R.; Heinrich, M.; George, S.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I
    Meeting Abstract

    Janku, F.; Chi, P.; Heinrich, M.; von Mehren, M.; Jones, R. L.; Ganjoo, K.; Trent, J.; Gelderblom, H.; Abdul Razak, A.; Gordon, M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update
    Meeting Abstract

    Jones, R. L.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M.; Kang, Y. K.; Schoeffski, P.; Cassier, P.; Mir, O.; Chawla, S. P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
    Meeting Abstract

    Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • State of the science: Uterine sarcomas: From pathology to practice
    Editorial

    Shushkevich, A.; Thaker, P. H.; Littell, R. D.; Shah, N. A.; Chiang, S.; Thornton, K.; Hensley, M. L.; Slomovitz, B. M.; Holcomb, K. M.; Leitao, M. M.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save